Literature DB >> 29145228

Author`s Reply.

Tolga Aksu1, Tümer Erdem Güler, Ferit Onur Mutluer.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29145228      PMCID: PMC5731297     

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, We would like to thank the authors for their scientific comments related to our recently published article (1) entitled “Vagal denervation in atrial fibrillation ablation: A comprehensive review.” published in Anatol J Cardiol 2017; 18:142-8. As mentioned by the authors, the inferior vena cava-left atrium fat pad (namely also ganglion C) located around the coronary sinus mainly provides vagal innervations and selectively innervates the atrio-ventricular node in humans (2, 3). Furthermore, this ganglion contains much more neurons than other ganglia (4). On the basis of this anatomical background, we only targeted ganglion C and performed the procedure using selective right atrial approach in patients with functional atrio-ventricular block (5, 6). Our selective right atrial approach was successful in six of seven patients. Considering the clinical features of failed case, this patient was the oldest patient in the study population. Therefore, we speculated that fibrosis of the conduction system due to advanced age may be the reason of unsuccessful ablation. In their study, Xhaet et al. (3) tried to reveal the importance of fat pads in the vagal control of the atrio-ventricular node. The study demonstrated that parasympathetic innervations of atrio-ventricular node were mainly provided by the integrity of the vagal ganglia but not directly by the right vagus nerve. This study may be a starting point for well-designed studies to clarify selective or integrative innervations principles of cardiac parasympathetic system. We thoroughly agree with the authors’ comments that there are some difficult questions that should be answered: (1) Which is the best method to define the exact location of vagal ganglia? (2) How can we achieve complete and permanent ablation? (3) Is there any importance of long-term effect of unrequited sympathetic activity after denervation? Future studies are needed to clarify all these dilemmas in patients with atrial fibrillation.
  6 in total

1.  Gross and microscopic anatomy of the human intrinsic cardiac nervous system.

Authors:  J A Armour; D A Murphy; B X Yuan; S Macdonald; D A Hopkins
Journal:  Anat Rec       Date:  1997-02

2.  Integrity of the Ganglionated Plexi Is Essential to Parasympathetic Innervation of the Atrioventricular Node by the Right Vagus Nerve.

Authors:  Olivier Xhaet; Luc DE Roy; Mariana Floria; Olivier Deceuninck; Dominique Blommaert; Fabien Dormal; Elisabeth Ballant; Mark LA Meir
Journal:  J Cardiovasc Electrophysiol       Date:  2017-01-31

3.  Simplified Cardioneuroablation in the Treatment of Reflex Syncope, Functional AV Block, and Sinus Node Dysfunction.

Authors:  Tolga Aksu; Ebru Golcuk; Kivanç Yalin; Tümer Erdem Guler; Ismail Erden
Journal:  Pacing Clin Electrophysiol       Date:  2015-10-26       Impact factor: 1.976

4.  Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation.

Authors:  Yinglong Hou; Benjamin J Scherlag; Jiaxiong Lin; Ying Zhang; Zhibing Lu; Kim Truong; Eugene Patterson; Ralph Lazzara; Warren M Jackman; Sunny S Po
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

5.  Functional permanent 2:1 atrioventricular block treated with cardioneuroablation: Case report.

Authors:  Tolga Aksu; Sukriye Ebru Golcuk; Tümer Erdem Guler; Kıvanç Yalin; Ismail Erden
Journal:  HeartRhythm Case Rep       Date:  2015-01-29

Review 6.  Vagal denervation in atrial fibrillation ablation: A comprehensive review.

Authors:  Tolga Aksu; Tümer Erdem Güler; Ferit Onur Mutluer; Mehmet Ali Oto
Journal:  Anatol J Cardiol       Date:  2017-07-25       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.